Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Lithium addition in treatment-resistant depression

C de Montigny¹

¹Department of Psychiatry, McGill University, Montreal.

International Clinical Psychopharmacology

|June 1, 1994

Summary

Adding lithium to antidepressants can help manage depression in patients unresponsive to standard treatments. This strategy shows consistent positive effects and a favorable safety profile for treatment-resistant depression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: an open trial.

International journal of geriatric psychiatry·2004

Same author

Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2001

Same author

Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2000

Same author

Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.

Neuropharmacology·2000

Same author

Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.

Neuropharmacology·2000

Same author

Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2000

Area of Science:

Neuroscience
Psychiatry
Pharmacology

Background:

Tricyclic antidepressants (TCAs) can increase postsynaptic neuron sensitivity with long-term use.
Lithium augmentation may enhance serotonin (5-HT) neuron function.
This mechanism suggests a potential benefit for treatment-resistant depression.

Purpose of the Study:

To evaluate the efficacy of lithium augmentation in patients with depression who do not respond to TCAs.
To assess the safety and tolerability of combining lithium with various antidepressants.

Main Methods:

Review of existing studies on lithium augmentation in non-responding depressed patients.
Analysis of reported adverse events associated with lithium-antidepressant combinations.

Main Results:

Consistent positive effects of lithium augmentation reported across multiple studies.
The combination of lithium with antidepressants did not lead to excessive serious adverse events.

Conclusions:

Lithium augmentation is a useful strategy for managing depression in patients with a poor response to antidepressants.
The approach appears safe and effective for treatment-resistant depression.

Related Experiment Videos